Casper Sek of Jingtian & Gongcheng examines China's long-awaited finalized standard contract provisions, and provides valuable guidance on how to prepare for the changes this will bring
Chinese state-owned enterprises urged to stop using Big Four due to data security concerns; small Chinese businesses to be subject to international data transfer requirements; and China encourages foreign investment in the real estate sector through private equity funds.
New CSRC rules on overseas listing; China raises concerns over Ford gaining access to Chinese electric battery technology; and CSRC clarifies that it will not impose a blanket ban on mainland investors trading overseas stocks
2022 regulatory trends in China, including data protection, TMT, capital markets, PE/VC, IP, dispute resolution, healthcare, banking & finance, sanctions and antitrust.
US Congress passes Act to protect American intellectual property; China plans measures to boost foreign investment centrally and locally; and deals in the life sciences sector are subject to strong CFIUS scrutiny.
Following an eventful year, Casper Sek of Jingtian & Gongcheng reviews the significant developments in China's data protection landscape for 2022, and ponders its further evolution in 2023
2022 was yet another action-packed year in China's TMT sector. Despite the continuity of platform regulation and new rules targeting emerging fields such as NFT and deepfake technologies, the momentum started to fade in the second half of the year in light of a slowing-down economy. Legislators are hoping such developments may navigate the more digitalized TMT sector through a tumultuous year ahead
The Chinese government has been deepening its reform over the past year in order to foster evolving regulatory framework. Deeper reforms coupled with a chilled market means life science companies should prioritize their assets and re-position their business strategies in order to survive and grow stronger.
